As of 2026-09-08, the Relative Valuation of Seres Therapeutics Inc (MCRB) is 64.46 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.72 USD, the upside of Seres Therapeutics Inc based on Relative Valuation is 1026.8%.
The range of the Relative Valuation is (62.66) - 213.71 USD.
| Range | Selected | |
| Trailing P/E multiples | 27.0x - 31.5x | 29.2x |
| Forward P/E multiples | 27.1x - 32.2x | 29.6x |
| Fair Price | (62.66) - 213.71 | 64.46 |
| Upside | -1195.4% - 3636.2% | 1026.8% |
| Date | P/E |
| 2026-09-04 | -2.46 |
| 2026-09-03 | -2.43 |
| 2026-09-02 | -2.39 |
| 2026-09-01 | -2.23 |
| 2026-08-31 | -2.12 |
| 2026-08-28 | -2.20 |
| 2026-08-27 | -2.13 |
| 2026-08-26 | -2.05 |
| 2026-08-25 | -2.15 |
| 2026-08-24 | -2.01 |
| 2026-08-21 | -1.97 |
| 2026-08-20 | -1.97 |
| 2026-08-19 | -2.02 |
| 2026-08-18 | -1.87 |
| 2026-08-17 | -1.94 |
| 2026-08-14 | -1.96 |
| 2026-08-13 | -1.93 |
| 2026-08-12 | -2.03 |
| 2026-08-11 | -2.00 |
| 2026-08-10 | -2.15 |
| 2026-08-07 | -2.10 |
| 2026-08-06 | -2.08 |
| 2026-08-05 | -2.16 |
| 2026-08-04 | -2.26 |
| 2026-08-03 | -2.17 |
| 2026-07-31 | -2.08 |
| 2026-07-30 | -2.06 |
| 2026-07-29 | -2.00 |
| 2026-07-28 | -2.07 |
| 2026-07-27 | -2.09 |
| 2026-07-24 | -2.14 |
| 2026-07-23 | -2.25 |
| 2026-07-22 | -2.28 |
| 2026-07-21 | -2.26 |
| 2026-07-20 | -2.20 |
| 2026-07-17 | -2.30 |
| 2026-07-16 | -2.23 |
| 2026-07-15 | -2.35 |
| 2026-07-14 | -2.30 |
| 2026-07-13 | -2.42 |
| 2026-07-10 | -2.63 |
| 2026-07-09 | -2.90 |
| 2026-07-08 | -3.08 |
| 2026-07-07 | -3.51 |
| 2026-07-06 | -3.32 |
| 2026-07-02 | -3.34 |
| 2026-07-01 | -3.42 |
| 2026-06-30 | -3.40 |
| 2026-06-29 | -3.36 |
| 2026-06-26 | -3.05 |